Regeneron Pharmaceuticals Inc (REGN)
639.58
+5.44
(+0.86%)
USD |
NASDAQ |
Mar 26, 16:00
639.97
+0.39
(+0.06%)
After-Hours: 17:26
Regeneron Pharmaceuticals Price to Book Value: 2.382 for March 26, 2025
View 4,000+ Financial Data Types:
Add
Browse
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Amgen Inc | 27.95 |
| Eli Lilly and Co | 52.33 |
| Merck & Co Inc | 4.807 |
| Pfizer Inc | 1.618 |
| Moderna Inc | 1.117 |
Price to Book Value Related Metrics
| PE Ratio | 16.71 |
| PS Ratio | 5.182 |
| PEG Ratio | 1.645 |
| Price to Free Cash Flow | 20.80 |
| Price | 639.58 |
| Earnings Yield | 5.99% |
| Market Cap | 69.92B |
| PEGY Ratio | 1.645 |
| Operating PE Ratio | 17.99 |
| Normalized PE Ratio | 16.75 |